報價延遲最少15分鐘:2025/01/21 08:42 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
263.69 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.87/5.01
|
|
企業價值
10.29B
|
| 資產負債 |
|
每股賬面淨值
28.77
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
1.06B
|
|
每股收益
25.93
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:42 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. |